ロード中...
Prognostic gene expression profiling in melanoma: necessary steps to incorporate into clinical practice
Prognostic gene expression profiling (GEP) tests for cutaneous melanoma (CM) are not recommended in current guidelines outside of a clinical trial. However, their use is becoming more prevalent and some practitioners are using GEP tests to guide patient management. Thus, there is an urgent need to b...
保存先:
| 出版年: | Melanoma Manag |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Medicine Ltd
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920745/ https://ncbi.nlm.nih.gov/pubmed/31871621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0016 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|